XML 64 R38.htm IDEA: XBRL DOCUMENT v3.24.4
EQUITY-BASED COMPENSATION (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Schedule of Fair Value Assumptions The fair value of the option grants awarded during the nine - month period ended September 30, 2024 was $0.1 million, which has been estimated with the following assumptions on the grant date.
Nine Months Ended
September 30 2024
Risk-free interest rate
4.25%-4.61%
Volatility
106.07% - 123.31%
Expected life (years)
5.00-6.00
Expected dividend yield%
The fair value of the option grants of $0.5 million has been estimated with the following assumptions for the year ended December 31, 2022:
2022
Risk-free interest rate
1.62%-1.70%
Volatility
125.19% - 126.42%
Expected life (years)
5 -6 years
Expected dividend yield0.00 %
Summary of Stock Option Activity
The following table summarizes stock option activity for employees and non-employees for the nine months ended September 30, 2024 and 2023:
Shares
Weighted-Average Exercise Price
Weighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 2022
13,391 $189.36 8.29
Granted— 
Exercised— 
Forfeited— 
Expired— 
Outstanding at September 30, 202313,391 $189.36 7.54
Exercisable at September 30, 20238,893 $226.40 7.36
Outstanding at December 31, 202311,164 $190.24 7.26
Granted21,125 $3.02 
Exercised— 
Forfeited735 
Expired— 
Outstanding at September 30, 202431,554 $66.75 8.45
Exercisable at September 30, 20249,086 $206.48 6.41
The following table summarizes stock option activity for employees and non-employees for the twelve months ended December 31, 2023 and 2022:
SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 20217,990 $550 8.50
Granted6,420 88 
Exercised— — 
Forfeited(847)— 
Expired(172)— 
Outstanding at December 31, 202213,391 $189 8.29
Exercisable at December 31, 20224,763 $287 7.63
Granted— $— 
Exercised— 
Forfeited(2,228)
Expired— 
Outstanding at December 31, 202311,163 $190 7.26
Exercisable at December 31, 20238,448 $212 7.13